HighTower Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$20K Buy
2020
Q4
Sell
2020
Q3
$117K Sell
2020
Q2
$141K Hold
2020
Q1
$159K Sell
2019
Q4
$265K Sell
2019
Q3
$333K Sell
2019
Q2
$867K Sell
2019
Q1
$518K Buy
2018
Q4
$251K Sell
2018
Q3
$748K Buy
2018
Q2
$812K Hold
2018
Q1
$725K Hold
2017
Q4
$1.05M Buy